Jianqing Bennett
CIK 1856691 · View on SEC EDGAR ↗
First SEC filing: May 4, 2021 · Latest: May 4, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 6, 2026 | WAT | F | 302 | $304.09 | $91,835 | 6,532 Direct | -4.42% | Disposed | 36.4% (price as of 2026-08-20) |
| March 2, 2026 | WAT | F | 410 | $307.23 | $125,964 | 6,834 Direct | -5.66% | Disposed | 35.0% (price as of 2026-08-20) |
| Feb. 25, 2026 | WAT | A | 4,826 | — | — | 4,826 Direct | — | Acquired | (price as of 2026-08-20) |
| Feb. 25, 2026 | WAT | A | 986 | — | — | 7,244 Direct | +15.76% | Acquired | (price as of 2026-08-20) |
| Feb. 5, 2026 | WAT | F | 43 | $376.89 | $16,206 | 6,258 Direct | -0.68% | Disposed | 10.1% (price as of 2026-08-20) |
| Feb. 4, 2026 | WAT | A | 1,385 | — | — | 6,301 Direct | +28.17% | Acquired | (price as of 2026-08-20) |
| April 7, 2025 | WAT | F | 303 | $325.80 | $98,717 | 4,916 Direct | -5.81% | Disposed | 27.3% (price as of 2026-08-20) |
| March 1, 2025 | WAT | F | 786 | $371.79 | $292,227 | 5,219 Direct | -13.09% | Disposed | 11.6% (price as of 2026-08-20) |
| Feb. 5, 2025 | WAT | A | 3,168 | — | — | 3,168 Direct | — | Acquired | (price as of 2026-08-20) |
| Feb. 5, 2025 | WAT | A | 615 | — | — | 6,005 Direct | +11.41% | Acquired | (price as of 2026-08-20) |
| Feb. 5, 2025 | WAT | A | 2,618 | — | — | 5,390 Direct | +94.44% | Acquired | (price as of 2026-08-20) |
| April 5, 2024 | WAT | F | 202 | $335.94 | $67,860 | 2,772 Direct | -6.79% | Disposed | 23.5% (price as of 2026-08-20) |
| Feb. 7, 2024 | WAT | A | 5,759 | — | — | 5,759 Direct | — | Acquired | (price as of 2026-08-20) |
| Feb. 7, 2024 | WAT | A | 5,759 | — | — | 5,759 Direct | — | Acquired | (price as of 2026-08-20) |
| April 5, 2023 | WAT | F | 204 | $302.66 | $61,743 | 2,974 Direct | -6.42% | Disposed | 37.1% (price as of 2026-08-20) |
| Feb. 8, 2023 | WAT | A | 5,679 | — | — | 5,679 Direct | — | Acquired | (price as of 2026-08-20) |
| April 5, 2022 | WAT | F | 204 | $305.35 | $62,291 | 3,178 Direct | -6.03% | Disposed | 35.8% (price as of 2026-08-20) |
| Feb. 17, 2022 | WAT | A | 7,013 | — | — | 7,013 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 25, 2026 | WAT | Stock Option (Right to Buy) | Common Stock (4,826) | $319.44 | Feb. 25, 2036 | 4,826 | Acquired |
| Feb. 5, 2025 | WAT | Stock Option (Right to Buy) | Common Stock (3,168) | $414.09 | Feb. 5, 2035 | 3,168 | Acquired |
| Feb. 7, 2024 | WAT | Stock Option (Right to Buy) | Common Stock (5,759) | $323.54 | Feb. 7, 2024 | 5,759 | Acquired |
| Feb. 7, 2024 | WAT | Stock Option (Right to Buy) | Common Stock (5,759) | $323.54 | Feb. 7, 2034 | 5,759 | Acquired |
| Feb. 8, 2023 | WAT | Stock Option (Right to Buy) | Common Stock (5,679) | $342.29 | Feb. 8, 2033 | 5,679 | Acquired |
| Feb. 17, 2022 | WAT | Stock Option (Right to Buy) | Common Stock (7,013) | $314.98 | Feb. 17, 2032 | 7,013 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
WAT
SVP, TA& Clinical Division| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $633,000 | — | — | — | $522,225 | — | $21,000 | $2,966,345 |
| 2024 | — | $771,406 | — | — | $24,300 | — | $2,503,063 | — |
| 2023 | — | $752,817 | — | — | $19,800 | — | $2,108,828 | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.